SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 3, 1994
Mallinckrodt Group Inc.
(Exact name of registrant as specified in its charter)
New York
(State or other jurisdiction of incorporation)
1-483
(Commission File Number)
36-1263901
(IRS Employer Identification No.)
7733 Forsyth Boulevard, St. Louis, MO
(Address of principal executive offices)
63105-1820
(Zip Code)
Registrant's telephone number including area code
(314) 854-5200
<PAGE>
Item 5. Other Events
A press release was issued October 3, 1994. The text of that
release is as follows:
MALLINCKRODT NAMES PRESIDENT FOR VETERINARY COMPANY;
FORMER MERCK EXECUTIVE BRINGS STRONG INDUSTRY EXPERIENCE
ST. LOUIS, MISSOURI, October 3, 1994 -- Mallinckrodt Group Inc.
(NYSE:MKG) announced today that Paul D. Cottone, formerly vice
president of U.S. operations for the Merck AgVet Division, has
joined Mallinckrodt Veterinary as president and chief executive
officer, effective October 1. Cottone also will serve as a
senior vice president of Mallinckrodt Group.
"We are extremely pleased to have attracted an animal health
industry executive of this caliber," said C. Ray Holman,
Mallinckrodt Group president and chief executive officer.
"Paul has extensive knowledge of the animal health industry,
strong U.S. and international experience in both the animal and
human health industries, and a solid business and management
portfolio with accountability for total operations for major
business segments. Mallinckrodt's firm commitment to our
animal health business is even stronger today with an
individual of Cottone's stature at the helm."
Cottone said, "I share the Mallinckrodt management team's
enthusiasm for the future of the animal health business, look
forward to building on the leadership position the company has
established over many years and am firmly committed to
achieving financial objectives that are expected to contribute
to the growth and success of the company."
Cottone's seven years of experience with Merck AgVet included
six years as executive director, international operations,
which included Canada, Australia, New Zealand, South Africa,
and Japan. In 1993, he was promoted to the position of vice
president, U.S. operations with the division.
He joined Merck Sharp & Dohme in 1972 and for four years sold
human health products to doctors and hospitals. He
subsequently held several product management sales and
marketing positions until 1982, when he was named director of
marketing and sales - MSD Australia. Cottone later was
managing director - MSD New Zealand and director of
Pharmaceutical operations - MSD Brazil. In 1986, he was named
senior director, U.S. Regional Operations.
A native of Brooklyn, New York, Cottone has a B.S. degree in
pharmacy from Fordham University (New York) and did post-
graduate work in the MBA program at Fairleigh Dickinson
University (New Jersey). He is a member of the board of
directors of the Animal Health Institute.
Mallinckrodt Group, a St. Louis-based Fortune 250 company, has
fiscal net sales of $1.94 billion. Through its three
technology-based businesses -- Mallinckrodt Chemical and
Mallinckrodt Medical, also headquarter in the St. Louis area,
and Mallinckrodt Veterinary, headquartered in Mundelein,
Illinois -- the company provides specialty chemicals and human
and animal health products. Mallinckrodt has 10,200 employees
worldwide.
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
Mallinckrodt Group Inc.
ROGER A. KELLER
Vice President, Secretary and General Counsel
DATE: October 19, 1994
